Correlation Between Meta Platforms and Evofem Biosciences
Can any of the company-specific risk be diversified away by investing in both Meta Platforms and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meta Platforms and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meta Platforms and Evofem Biosciences, you can compare the effects of market volatilities on Meta Platforms and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meta Platforms with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meta Platforms and Evofem Biosciences.
Diversification Opportunities for Meta Platforms and Evofem Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Meta and Evofem is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Meta Platforms and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Meta Platforms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meta Platforms are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Meta Platforms i.e., Meta Platforms and Evofem Biosciences go up and down completely randomly.
Pair Corralation between Meta Platforms and Evofem Biosciences
If you would invest 61,072 in Meta Platforms on November 9, 2024 and sell it today you would earn a total of 10,127 from holding Meta Platforms or generate 16.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Meta Platforms vs. Evofem Biosciences
Performance |
| Timeline |
| Meta Platforms |
| Evofem Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Meta Platforms and Evofem Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Meta Platforms and Evofem Biosciences
The main advantage of trading using opposite Meta Platforms and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meta Platforms position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.| Meta Platforms vs. Alphabet Inc Class A | Meta Platforms vs. Twilio Inc | Meta Platforms vs. Snap Inc | Meta Platforms vs. Baidu Inc |
| Evofem Biosciences vs. CLPS Inc | Evofem Biosciences vs. Primo Brands | Evofem Biosciences vs. ScanSource | Evofem Biosciences vs. CDW Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |